An official website of the United States government
The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases.
Strategic Plan
Almost every household in America is affected by diseases of the bones, joints, muscles, and skin. NIAMS works to understand and treat such diseases and conditions. We support research through our extramural and intramural programs.
Storing, managing, standardizing, and publishing the vast amounts of data produced by biomedical research is a critical component to the mission of NIAMS and NIH. The research on arthritis, autoimmune, musculoskeletal, and skin diseases generates datasets of significant sizes and variety which provide a great scope for data science and its applications. Learn more about NIAMS Data Science, Management, and Sharing.
Community Engagement
The NIAMS Coalition is an independent consortium of professional and voluntary organizations that is national in scope.
Science Partnerships
Accelerating Medicines Partnership® (AMP®) Program
The Accelerating Medicines Partnership® seeks to transform the current model for developing diagnostics and treatments by increasing efficiency, improving the process, and increasing the number and effectiveness of new targeted therapies.
Molecular Transducers of Physical Activity Consortium
The Molecular Transducers of Physical Activity Consortium (MoTrPAC) aims to uncover, at the molecular level, how exercise improves and maintains the health of the body’s tissues and organs.
Working Groups and Committees
NIAMS Advisory Council
The Council meets to advise NIAMS about its research portfolio and broader issues of science policy and provides peer review of grant applications.
NIAMS Board of Scientific Counselors
The NIAMS Board of Scientific Counselors (BSC) regularly reviews the Institute’s Intramural Research Program, in compliance with NIH guidelines.
Lupus Federal Working Group
The Lupus Federal Working Group is composed of representatives from all relevant HHS agencies and any other government agency having an interest in lupus.
Muscular Dystrophy Coordination Committee
The Muscular Dystrophy Coordinating Committee coordinates activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy (MD).